Romvimza
Vimseltinib · Deciphera Pharmaceuticals, LLC
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Romvimza ingredients
| Active ingredient | Strength |
|---|---|
| Vimseltinib | 20 mg/1, 30 mg/1, 14 mg/1 |
What Romvimza is used for
Romvimza is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Romvimza
- Generic name
- Vimseltinib
- Made by
- Deciphera Pharmaceuticals, LLC
- Forms
- Capsule
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA219304
- On the US market since
- 2025
Official information
- Romvimza prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Vimseltinib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Romvimza?
Romvimza (Vimseltinib) is a cancer medicine made by Deciphera Pharmaceuticals, LLC, approved by the US FDA.
What are the ingredients of Romvimza?
Romvimza contains Vimseltinib (20 mg/1, 30 mg/1, 14 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA